RhumbLine Advisers’s NextCure NXTC Stock Holding History

RhumbLine Advisers’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-59	Closed	-$1.12K	–	4289
2024 Q2	$1.12K	Hold	59	–	–	﹤0.01%	4232
2024 Q1	$1.57K	Hold	59	–	–	﹤0.01%	4108
2023 Q4	$801	Hold	59	–	–	﹤0.01%	4166
2023 Q3	$906	Hold	59	–	–	﹤0.01%	4191
2023 Q2	$1.26K	Buy	+59	New	+$1.16K	﹤0.01%	4267
2021 Q2	–	Sell	-1,555	Closed	-$187K	–	3073
2021 Q1	$187K	Sell	1,555 -67	-4%	-$9.7K	﹤0.01%	2847
2020 Q4	$212K	Buy	1,622 +113	+7%	+$14.6K	﹤0.01%	2816
2020 Q3	$159K	Sell	1,509 -242	-14%	-$29.8K	﹤0.01%	2754
2020 Q2	$450K	Buy	1,751 +304	+21%	+$116K	﹤0.01%	2398
2020 Q1	$644K	Buy	1,447 +139	+11%	+$74.2K	﹤0.01%	2061
2019 Q4	$884K	Buy	+1,308	New	+$656K	﹤0.01%	2139

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RhumbLine Advisers's NXTC Position: Q3 2024 in Review

RhumbLine Advisers sold out of NextCure (NXTC) in Q3 2024, closing a stake of 59 shares — an estimated $1.12K sold.

RhumbLine Advisers first reported a position in NXTC in Q4 2019 and held it in 11 quarters. The position peaked at $884K in Q4 2019. 43 funds tracked by Wall St. Rank hold NXTC as of Q3 2024.

RhumbLine Advisers reported no remaining NextCure position as of Q3 2024 after selling out during the quarter.
RhumbLine Advisers sold 59 NextCure shares in Q3 2024, an estimated $1.12K.
RhumbLine Advisers first reported a position in NextCure in Q4 2019 and held it in 11 quarters.
RhumbLine Advisers's NextCure position peaked at $884K in Q4 2019.
43 funds tracked by Wall St. Rank held NextCure as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.